Veeva Systems Inc. Class A VEEV
NYSE · United States · Technology Services
$285.45+6.88 (+2.47%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Veeva Systems (NYSE: VEEV) today announced that Servier is standardizing customer reference data across more than 80 countries with Veeva OpenData. Building on its global success with Veeva Link Key People, a leading French pharmaceutical company governed by a Foundation, is harmonizing customer reference data and creating a unified foundation to scale AI.
Veeva Systems has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Veeva Quality Cloud and Amgen planning a global deployment of Veeva Vault CRM. Together, these developments highlight Veeva’s push to embed agentic AI across clinical, safety, quality, and commercial workflows, reinforcing its role as an end-to-end software partner for life sciences...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.